Reuters logo
BRIEF-Biomarin reports Q3 loss $0.07/shr
2017年10月26日 / 晚上9点15分 / 1 个月前

BRIEF-Biomarin reports Q3 loss $0.07/shr

Oct 26 (Reuters) - Biomarin Pharmaceutical Inc

* Biomarin announces third quarter 2017 financial results

* Q3 GAAP loss per share $0.07

* Q3 earnings per share view $-0.14 -- Thomson Reuters I/B/E/S

* Sees FY 2017 revenue $1.29 billion to $1.32 billion

* Q3 revenue $334.1 million versus I/B/E/S view $347.4 million

* FY2017 revenue view $1.31 billion -- Thomson Reuters I/B/E/S

* Biomarin Pharmaceutical Inc sees ‍ full-year non-GAAP income $60 million to $80 million ​

* Biomarin Pharmaceutical Inc sees ‍full-year GAAP net loss $110 to $130​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below